http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008118879-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7478f83e77362f224df93a2c466bca2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_13a08a32770968c34c319d10f6cb1643
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4d121c7abfaaeb49b0e383527ade50a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
filingDate 2008-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ee9f0ff8acc4a52dd4779d7f4e6d57b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f16a27e5d6836750de39e37a95e56c0b
publicationDate 2009-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2008118879-A3
titleOfInvention Antiviral compositions comprising 2 compounds
abstract Described herein are compounds useful in the treatment of viral diseases, compositions comprising them and methods of using them. The compounds comprise a nucleoside or nucleoside analog linked, commonly through a phosphate group to one of a selected group of lipids. In some embodiments, the compounds described herein are useful for treating HIV infection, AIDS and other viral infections.
priorityDate 2007-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02087465-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6030960-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9119726-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9529176-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397646

Total number of triples: 34.